{"id":94160,"date":"2025-09-10T19:00:36","date_gmt":"2025-09-11T00:00:36","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?p=94160"},"modified":"2025-09-10T19:03:14","modified_gmt":"2025-09-11T00:03:14","slug":"gratulerer-til-laura-eurelings-md-phd-2","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/nb\/congratulations-to-laura-eurelings-md-phd\/","title":{"rendered":"Gratulerer til Laura Eurelings, MD, PhD!"},"content":{"rendered":"<p>Ved\u00a0<strong>2025 Erdhem-Chester Disease Medical Symposium in Barcelona<\/strong>, den\u00a0<strong>ECDGA-prisen for unge forskere<\/strong>\u00a0dro til\u00a0<strong>Laura Eurelings<\/strong>\u00a0ved Erasmus Universitetssykehus i Rotterdam.<\/p>\n<p>Plakaten hennes,\u00a0<em>\u201cAnti-IL-6-behandling ved sjeldne histiocytiske sykdommer: Erdheim-Chester-syndrom og Rosai-Dorfman-syndrom\u201d,\u201d<\/em>\u00a0viste at\u00a0<strong>Tocilizumab kan potensielt v\u00e6re et effektivt alternativ for pasienter<\/strong>, s\u00e6rlig de som er mutasjonsnegative eller som ikke er egnet for behandling med BRAF-hemmere.<\/p>\n<p>N\u00e5r forskere i begynnelsen av karrieren engasjerer seg i forskning, bidrar de med friske ideer og ny energi \u2013 noe som er med p\u00e5 \u00e5 drive forskningen p\u00e5 sjeldne sykdommer fremover. Lauras arbeid er et perfekt eksempel p\u00e5 hvordan unge forskere gj\u00f8r en reell forskjell og bidrar til \u00e5 \u00f8ke kunnskapen om ECD!<\/p>\n<p>Join us in celebrating Laura\u2019s achievement and her contribution to the ECD community.<\/p>","protected":false},"excerpt":{"rendered":"<p>At the\u00a02025 Erdhem-Chester Disease Medical Symposium in Barcelona, the\u00a0ECDGA Junior Investigator Award\u00a0went to\u00a0Laura Eurelings\u00a0of Erasmus University Medical Centre, Rotterdam. Her poster,\u00a0\u201cAnti-IL-6 Therapy in Rare Histiocytic Disorders: Erdheim-Chester and Rosai-Dorfman Disease,\u201d\u00a0showed [&hellip;]<\/p>\n","protected":false},"author":14,"featured_media":94197,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[51],"tags":[3190,387,374,4654,2395,4254],"class_list":["post-94160","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-ecd","tag-ecdga","tag-erdheimchesterdisease","tag-futureofresearch","tag-medicalsymposium","tag-rarediseaseresearch"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/posts\/94160","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/users\/14"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/comments?post=94160"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/posts\/94160\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/media\/94197"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/media?parent=94160"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/categories?post=94160"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nb\/wp-json\/wp\/v2\/tags?post=94160"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}